282 related articles for article (PubMed ID: 25607819)
1. Dense collagen-I matrices enhance pro-tumorigenic estrogen-prolactin crosstalk in MCF-7 and T47D breast cancer cells.
Barcus CE; Holt EC; Keely PJ; Eliceiri KW; Schuler LA
PLoS One; 2015; 10(1):e0116891. PubMed ID: 25607819
[TBL] [Abstract][Full Text] [Related]
2. Stiff collagen matrices increase tumorigenic prolactin signaling in breast cancer cells.
Barcus CE; Keely PJ; Eliceiri KW; Schuler LA
J Biol Chem; 2013 May; 288(18):12722-32. PubMed ID: 23530035
[TBL] [Abstract][Full Text] [Related]
3. Prolactin and estradiol utilize distinct mechanisms to increase serine-118 phosphorylation and decrease levels of estrogen receptor alpha in T47D breast cancer cells.
Chen Y; Huang K; Chen KE; Walker AM
Breast Cancer Res Treat; 2010 Apr; 120(2):369-77. PubMed ID: 19377875
[TBL] [Abstract][Full Text] [Related]
4. Prolactin induces up-regulation of its cognate receptor in breast cancer cells via transcriptional activation of its generic promoter by cross-talk between ERα and STAT5.
Kavarthapu R; Tsai Morris CH; Dufau ML
Oncotarget; 2014 Oct; 5(19):9079-91. PubMed ID: 25193864
[TBL] [Abstract][Full Text] [Related]
5. Estrogen receptor alpha mediates epithelial to mesenchymal transition, expression of specific matrix effectors and functional properties of breast cancer cells.
Bouris P; Skandalis SS; Piperigkou Z; Afratis N; Karamanou K; Aletras AJ; Moustakas A; Theocharis AD; Karamanos NK
Matrix Biol; 2015 Apr; 43():42-60. PubMed ID: 25728938
[TBL] [Abstract][Full Text] [Related]
6. Activation of the unliganded estrogen receptor by prolactin in breast cancer cells.
González L; Zambrano A; Lazaro-Trueba I; Lopéz E; González JJ; Martín-Pérez J; Aranda A
Oncogene; 2009 Mar; 28(10):1298-308. PubMed ID: 19169277
[TBL] [Abstract][Full Text] [Related]
7. Role of EGF/ERBB1 in the transcriptional regulation of the prolactin receptor independent of estrogen and prolactin in breast cancer cells.
Kavarthapu R; Dufau ML
Oncotarget; 2016 Oct; 7(40):65602-65613. PubMed ID: 27564112
[TBL] [Abstract][Full Text] [Related]
8. Global profiling of prolactin-modulated transcripts in breast cancer in vivo.
Sato T; Tran TH; Peck AR; Liu C; Ertel A; Lin J; Neilson LM; Rui H
Mol Cancer; 2013 Jun; 12():59. PubMed ID: 23758962
[TBL] [Abstract][Full Text] [Related]
9. Endogenous human prolactin and not exogenous human prolactin induces estrogen receptor alpha and prolactin receptor expression and increases estrogen responsiveness in breast cancer cells.
Gutzman JH; Miller KK; Schuler LA
J Steroid Biochem Mol Biol; 2004 Jan; 88(1):69-77. PubMed ID: 15026085
[TBL] [Abstract][Full Text] [Related]
10. Prolactin-growth factor crosstalk reduces mammary estrogen responsiveness despite elevated ERalpha expression.
Arendt LM; Grafwallner-Huseth TL; Schuler LA
Am J Pathol; 2009 Mar; 174(3):1065-74. PubMed ID: 19179608
[TBL] [Abstract][Full Text] [Related]
11. Prolactin-induced mouse mammary carcinomas model estrogen resistant luminal breast cancer.
Arendt LM; Rugowski DE; Grafwallner-Huseth TA; Garcia-Barchino MJ; Rui H; Schuler LA
Breast Cancer Res; 2011 Jan; 13(1):R11. PubMed ID: 21276249
[TBL] [Abstract][Full Text] [Related]
12. Genistein modulates proliferation and mitochondrial functionality in breast cancer cells depending on ERalpha/ERbeta ratio.
Pons DG; Nadal-Serrano M; Blanquer-Rossello MM; Sastre-Serra J; Oliver J; Roca P
J Cell Biochem; 2014 May; 115(5):949-58. PubMed ID: 24375531
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the coordinated actions of estrogen receptors with epidermal growth factor receptor and insulin-like growth factor receptor in the expression of cell surface heparan sulfate proteoglycans and cell motility in breast cancer cells.
Tsonis AI; Afratis N; Gialeli C; Ellina MI; Piperigkou Z; Skandalis SS; Theocharis AD; Tzanakakis GN; Karamanos NK
FEBS J; 2013 May; 280(10):2248-59. PubMed ID: 23374155
[TBL] [Abstract][Full Text] [Related]
14. CAT-1-mediated arginine uptake and regulation of nitric oxide synthases for the survival of human breast cancer cell lines.
Abdelmagid SA; Rickard JA; McDonald WJ; Thomas LN; Too CK
J Cell Biochem; 2011 Apr; 112(4):1084-92. PubMed ID: 21308737
[TBL] [Abstract][Full Text] [Related]
15. Autocrine regulation of cell proliferation by estrogen receptor-alpha in estrogen receptor-alpha-positive breast cancer cell lines.
Tan H; Zhong Y; Pan Z
BMC Cancer; 2009 Jan; 9():31. PubMed ID: 19171042
[TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor receptor cross-talks with ligand-occupied estrogen receptor-alpha to modulate both lactotroph proliferation and prolactin gene expression.
Chen S; Bangaru ML; Sneade L; Dunckley JA; Ben-Jonathan N; Kansra S
Am J Physiol Endocrinol Metab; 2009 Aug; 297(2):E331-9. PubMed ID: 19470835
[TBL] [Abstract][Full Text] [Related]
17. The prolactin receptor transactivation domain is associated with steroid hormone receptor expression and malignant progression of breast cancer.
Fiorillo AA; Medler TR; Feeney YB; Wetz SM; Tommerdahl KL; Clevenger CV
Am J Pathol; 2013 Jan; 182(1):217-33. PubMed ID: 23159947
[TBL] [Abstract][Full Text] [Related]
18. Prolactin and estrogen enhance the activity of activating protein 1 in breast cancer cells: role of extracellularly regulated kinase 1/2-mediated signals to c-fos.
Gutzman JH; Nikolai SE; Rugowski DE; Watters JJ; Schuler LA
Mol Endocrinol; 2005 Jul; 19(7):1765-78. PubMed ID: 15746191
[TBL] [Abstract][Full Text] [Related]
19. Low levels of 3,3'-diindolylmethane activate estrogen receptor α and induce proliferation of breast cancer cells in the absence of estradiol.
Marques M; Laflamme L; Benassou I; Cissokho C; Guillemette B; Gaudreau L
BMC Cancer; 2014 Jul; 14():524. PubMed ID: 25048790
[TBL] [Abstract][Full Text] [Related]
20. 17β-Estradiol treatment inhibits breast cell proliferation, migration and invasion by decreasing MALAT-1 RNA level.
Zhao Z; Chen C; Liu Y; Wu C
Biochem Biophys Res Commun; 2014 Mar; 445(2):388-93. PubMed ID: 24525122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
